Evaluation of Acute Hyponatremia
Begin evaluation of acute hyponatremia by immediately assessing symptom severity and measuring serum osmolality, urine osmolality, urine sodium, and determining volume status through clinical examination and laboratory parameters—this systematic approach is critical because treatment varies dramatically based on the underlying cause and can be life-threatening if mismanaged 1.
Initial Diagnostic Workup
When serum sodium falls below 131 mmol/L (or 135 mmol/L by some criteria), initiate the following evaluation 1, 2:
Essential Laboratory Tests
- Serum osmolality: Distinguish true hypotonic hyponatremia from pseudohyponatremia (which occurs with hyperglycemia or hypertriglyceridemia and shows normal/high osmolality >280 mOsm/kg)
- Urine osmolality: Values >100-300 mOsm/kg suggest inappropriate ADH activity
- Urine sodium concentration: >20-40 mEq/L indicates renal sodium loss
- Serum uric acid: <4 mg/dL supports SIADH 2
- Thyroid and adrenal function: Must exclude hypothyroidism and hypocortisolism before diagnosing SIADH 2
Volume Status Assessment
The key to distinguishing between cerebral salt wasting (CSW) and SIADH is determining extracellular fluid volume status 1. This requires:
- Clinical examination: Look for orthostatic hypotension, tachycardia, dry mucous membranes (hypovolemia) versus edema, ascites, jugular venous distension (hypervolemia)
- Central venous pressure monitoring when available and indicated 1
- Fractional excretion of urate: Can improve diagnostic accuracy to 95% for SIADH 2
- Daily weights and strict intake/output monitoring 1
Diagnostic Algorithm by Volume Status
Hypovolemic Hyponatremia
- Urine sodium <20 mEq/L: Extrarenal losses (vomiting, diarrhea, third-spacing)
- Urine sodium >20 mEq/L: Renal losses (diuretics, CSW, adrenal insufficiency) 1
Euvolemic Hyponatremia
After excluding hypothyroidism, hypocortisolism, and polydipsia, diagnose SIADH with:
- Plasma osmolality <275 mOsm/kg
- Urine osmolality >300-500 mOsm/kg (inappropriately concentrated)
- Urine sodium >40 mEq/L
- Clinical euvolemia
- Serum uric acid <4 mg/dL 2
Hypervolemic Hyponatremia
Rule out heart failure, cirrhosis, nephrotic syndrome, and renal failure 1
Critical Symptom Assessment
Symptom severity—not just the sodium level—determines treatment urgency 1:
Severe Symptoms (Medical Emergency)
- Seizures, coma, obtundation
- Cardiorespiratory distress
- Abnormal and deep somnolence
- Mental status changes with sodium <120 mmol/L
These indicate cerebral edema and require immediate hypertonic saline 2, 1, 3.
Mild-Moderate Symptoms
- Confusion, headache, nausea
- General weakness
- Typically occur at sodium 125-130 mmol/L 2
Asymptomatic
- May still require treatment if sodium <131 mmol/L, especially in neurosurgical patients or those at risk for vasospasm 1
Timing Assessment: Acute vs. Chronic
Distinguish acute (<48 hours) from chronic (>48 hours) hyponatremia because rapid correction of chronic hyponatremia risks osmotic demyelination syndrome 1, 4, 3:
- Acute hyponatremia: More symptomatic, tolerates faster correction
- Chronic hyponatremia: Often less symptomatic but requires slower correction (maximum 8-10 mmol/L per 24 hours) 1
Common Pitfalls to Avoid
Do not measure ADH or natriuretic peptide levels—they are not supported by evidence and do not aid diagnosis 1
Do not rely solely on clinical volume assessment—it can be inaccurate. Use objective measures including urine studies, fractional excretion of urate, and invasive monitoring when needed 1, 2
Do not assume all euvolemic hyponatremia is SIADH—always exclude hypothyroidism, adrenal insufficiency, and consider other causes like atrial natriuretic peptide-mediated hyponatremia 2
Do not treat hyponatremia in subarachnoid hemorrhage patients at risk for vasospasm with fluid restriction—this can worsen outcomes 1
In cirrhotic patients, always evaluate for infection with diagnostic paracentesis—hyponatremia may signal acute inflammation 5
Special Populations
Neurosurgical Patients
- Treat sodium ≥131 mmol/L in subarachnoid hemorrhage patients at risk for vasospasm
- Distinguish CSW (treat with volume and sodium replacement) from SIADH (treat with fluid restriction)
- Consider fludrocortisone and hydrocortisone in SAH patients 1
Cirrhotic Patients
- Document daily sodium/fluid intake, medications (diuretics, laxatives)
- Assess for precipitants including infection, alcohol use
- Check renal, thyroid, adrenal, and cardiac function
- Pseudohyponatremia is common with hypertriglyceridemia 5
The evaluation must be completed rapidly in symptomatic patients, with treatment initiated within 1-2 hours for severe symptoms while simultaneously pursuing diagnostic workup 1, 3.